Meeting the Unmet Need in the Management of MDR Gram-Positive Infections with Oral Bactericidal Agent Levonadifloxacin
Sign Up to like & getrecommendations! Published in 2022 at "Critical Care Research and Practice"
DOI: 10.1155/2022/2668199
Abstract: Levonadifloxacin (intravenous) and its oral prodrug alalevonadifloxacin are broad-spectrum antibacterial agents developed for the treatment of difficult-to-treat infections caused by multidrug-resistant Gram-positive bacteria, especially methicillin-resistant Staphylococcus aureus, atypical bacteria, anaerobic bacteria, and biodefence pathogens as… read more here.
Keywords: gram; meeting unmet; need management; unmet need ... See more keywords